Organic Active Ingredients TRIZ Cases

Bifunctional quaternary ammonium compounds combine beta2-adrenoreceptor agonist and M receptor antagonist activities.

Thiazole methanone compounds antagonize TRPM8 receptors to treat urological disorders while reducing side effects.

Human milk oligosaccharides shift intestinal metabolism to saccharolytic pathways, reducing ammonia and branched chain fatty acids.

Acylated polyethylene glycol-poly(lactide-co-caprolactone) copolymers prevent burst release of water-soluble drugs while maintaining imaging visibility.

Small molecules targeting the GLI3 activator domain induce apoptosis in cancer cells while sparing normal tissue function.

Novel substituted N-acetyl-L-cysteine derivatives modify molecular parameters to improve blood-brain barrier crossing and increase brain glutathione levels.

Enzymatic reduction of ketones using oxidoreductase enzymes produces chiral 2-(4-aminophenyl) morpholines with high enantiomeric excess.

Bacterial activation of azo prodrugs releases PDE4 inhibitors locally, avoiding systemic side effects from oral anti-inflammatory delivery.

Exogenous CLIP peptides protect mucosal cells from autoimmune damage by blocking MHC class I or II mediated cell death pathways.

KIF18A inhibitors treat neoplastic diseases by inducing tumor regression in patients with TP53, Rb1, CCNE1, or BRCA alterations.

Nitrogen flushing and light-blocking containers prevent clevidipine oxidation, keeping H324/78 impurities below 0.2%.

Novel pyrazine derivatives modulate potassium channels through targeted molecular structures.

Formulated with specific pH and viscosity, the gel alleviates vulvovaginal pain without systemic side effects.

Fused triazolo pyrazine derivatives antagonize ATP at the P2X7 receptor to treat inflammatory and neuropathic pain.

Water-based phospholipid depots enable fine needle injection while maintaining drug stability.

Segmented oral appliance dispenses chlorhexidine through hydrogel carriers to treat deep periodontal pockets while reducing bitter taste exposure.

Merging cardiomyocytes with epicardial cells resolves low engraftment efficiency by providing a supportive microenvironment for heart tissue regeneration.

Engineered cytochrome P450 monooxygenases replace toxic chemical synthesis with biocatalytic oxidation of camptothecin, improving yield and safety.

Combines crenolanib with apoptotic pathway agents to overcome resistance in FLT3-mutated cells.

Analyzing bile fluid biomarkers enables non-invasive cholangiocarcinoma detection, avoiding invasive tissue biopsy.

Hot melt extrusion creates a Tapentadol matrix that prevents parenteral abuse by forming an insoluble gel.

Combining FXR and PPAR agonists reduces liver triglycerides and oxidative stress in NAFLD and NASH patients.

Trans sodium crocetinate enhances oxygen diffusivity to improve tissue hypoxia without causing hyperoxygenation.

EFdA nucleoside reverse transcriptase inhibitor enables potent viral suppression with less frequent dosing to improve patient adherence.

Combining pemafibrate and tofogliflozin reduces liver stiffness and fibrosis in nonalcoholic steatohepatitis patients.

Pre-prepared alkalized anesthetic in sterile bag eliminates manual mixing, reducing contamination risk while maintaining optimal diffusion properties.

Genistein nanoparticle compositions mitigate ionizing radiation exposure through antioxidant activity and cellular uptake mechanisms.

Crystal form A of an SGLT inhibitor reduces adverse reactions and improves glycemic control via stable crystalline structures.

Short fibrinogen-derived peptides bind ICAM-1 to transport therapeutic agents, reducing immunogenicity compared to antibody-based systems.

Thiazole derivatives suppress viral replication while avoiding ribavirin-associated side effects like anemia and teratogenicity.

Antisense oligonucleotides induce GLDC exon skipping to arrest cell cycles and trigger apoptosis without harming normal tissue.

A 4-hydroxybutyl L-tryptophanate conjugate transports therapeutic agents across cellular membranes.

New dioxazine chemotypes increase enzyme levels by 1.5-fold, addressing limited efficacy of existing treatments.

Enzyme conjugates bind tumor vasculature endothelial cells, converting non-toxic prodrugs into active anticancer drugs locally to reduce systemic toxicity.

Replacing propylene glycol with an alcohol and alpha-hydroxy acid mixture increases minoxidil solubility while reducing skin irritation.

Fullerene mixed with lipid solutions creates a carrier that dissolves hydrophobic agents without surfactant toxicity or sterilization barriers.

Compounds bind the BAX trigger site to stabilize inactive structures and prevent unwanted cell death in disease models.

Enzymatic decarboxylation converts THCA to THC in cannabis extracts, preserving volatile terpenes lost during oven heating.

L-tryptophan reduces parasomnia frequency and severity while eliminating fatigue side effects from traditional pharmacotherapies.

Co-administering HQP-1351 and asciminib overcomes T315I drug resistance by downregulating phosphorylation.

Antithrombotic nanoparticles deliver thrombin inhibitors to block platelet activation in necrotizing enterocolitis.

Substituted triazole derivatives act as positive allosteric modulators to enhance nicotinic receptor agonist efficacy without causing desensitization.

Combination therapy raises testosterone while inhibiting conversion to estradiol, reducing beta-amyloid production to slow Alzheimer's disease progression.

Combining a human anti-IGF antibody with exemestane and everolimus prevents AKT phosphorylation, overcoming endocrine therapy resistance.

Ultrasonic cavitation synthesizes naringenin nanoparticles that reduce cadmium bioaccumulation and heat shock protein 70 levels in fish tissues.